Background: Although the adhesive mechanisms underlying the capture and immobilization of circulating neutrophils in inflamed blood vessels have been well described, factors controlling the subsequent migration of neutrophils over and through the blood vessel endothelium are poorly understood. Directional rearrangement of the actin cytoskeleton within the neutrophil, along with modulation of integrin-mediated adhesion, are necessary for neutrophil migration. Signals from chemotactic agents and from the adhesive substrate may regulate these processes, but little is known about their relative importance or their mode of integration.
Background
During the development of an inflammatory response, neutrophils are captured from the circulation through a series of adhesive interactions with the vessel wall that culminate in the migration of the neutrophils into extravascular tissue [1, 2] . Recruitment is initiated with the rolling of neutrophils on selectins expressed on the endothelial cells lining the vessel wall, which slows the neutrophils down and allows the transmission of chemotactic signals from the endothelium. Neutrophil ␤2 integrins, activated as a consequence of these chemotactic signals, then mediate stationary adhesion by binding to members of the immunoglobulin superfamily expressed on the endothelial surface. Activated immobilized platelets can also support both neutrophil rolling via the expression of P-selectin on the platelet surface, and neutrophil arrest via interaction of ␤2 integrin (CD11b/CD18) expressed on the neutrophil with an unidentified platelet ligand [3] [4] [5] . Although integrin-mediated adhesion appears essential for the onward migration of neutrophils on endothelial cells or platelets [4] [5] [6] , the factors controlling this migration phase are not well understood.
In general, migration requires directional rearrangement of the actin cytoskeleton that is the 'motor' for locomotion, along with modulation of integrin-mediated adhesion in such a way that movement is allowed without the cells detaching from the surface [7] . Both integrin activation and actin polymerization are induced in leucocytes by a range of chemokines and inflammatory agents [8] . In experimental studies of neutrophil migration over platelets or immobilized albumin, a continuous supply of the neutrophil-activating agent (formyl tripeptide, f-Met-Leu-Phe or fMLP) was required to maintain attachment, which itself depended on the activation of newly expressed ␤2 integrin while existing activated integrin was downregulated [4, 9] . Analogous transient activation and deactivation of VLA-4 (␣4␤1 integrin) precedes VLA-5 (␣5␤1 integrin) activation during monocyte migration induced by the chemokine MCP-1 [10] . Thus, triggering of integrins by chemical agents, followed by regulation of cytoskeletal and integrin activity may be general strategies to allow sustained cellular adhesion and migration.
There remains the problem of how direction and rate of migration are controlled. Neutrophils are capable of moving preferentially along a concentration gradient of soluble chemoattractant, and the steepness of such a gradient can affect the rate of migration [11] . Such a gradient cannot exist, however, in a perfused blood vessel, where cells might be guided by a haptotactic gradient dependent on the distribution of a localized adhesion receptor. CD31 is a candidate for this type of regulation of migration, because binding of ligand to CD31 has been demonstrated to influence transendothelial migration of neutrophils in vitro and in vivo [12, 13] . This surface molecule is expressed by endothelial cells, platelets and leucocytes and can support cell-cell adhesion via homophilic CD31-CD31 binding or binding to ␣v␤3 integrin [14] [15] [16] . Binding of ligand to CD31 also activates ␤1 and ␤2 integrins in a number of cells, possibly through signal transduction mediated by homophilic interactions [16] [17] [18] . For natural killer (NK) lymphocytes, antibody-mediated oligomerization of CD31 induces cytoskeletal rearrangement and integrin-mediated cell-spreading in a process that is dependent on cAMP [19] . Thus, CD31 ligandbinding may be hypothesized to influence migration either by supporting adhesion or by modulating integrin or cytoskeletal functions.
In this study, we set out to examine how adhesive and chemokinetic signals were integrated in controlling the rate of migration of neutrophils over activated platelets or purified adhesion receptors. Using an in vitro flow-based assay and time-lapse videomicroscopy, it was possible to deliver activating agents rapidly to neutrophils already rolling on platelets or immobilized P-selectin, and to measure the kinetics of migration immediately thereafter. Performing the assays under flow conditions also ensured that agents generated by activated neutrophils themselves were rapidly washed away (as occurs in vivo), so that we could directly examine the role of accessory adhesive mechanisms without the complication of autocrine neutrophil responses. We found that binding of ligand to both CD31 and P-selectin increased the migration rate of activated neutrophils over platelets, and that these effects could be reproduced by combining the immobilized purified receptors. As migration was primarily supported by CD11b/CD18, our results demonstrate that CD31 and P-selectin act as accessory signalling molecules to modulate integrin-mediated migration of neutrophils. In a general sense, such 'cross-talk' between cell-surface receptors might represent a more important role for some cell adhesion molecules than their more classical ligandbinding properties, and might begin to provide a molecular explanation for the requirement of a number of distinct cell surface receptors to be engaged for efficient cell function to occur.
Results

Rate of neutrophil migration across platelet monolayers
The great majority of adherent neutrophils (> 95%) perfused over platelet monolayers were rolling and had a velocity of 1.9 ± 0.15 m sec -1 (mean ± SEM of 60 cells from three experiments). After superfusion of fMLP or platelet-activating factor (PAF), neutrophils stopped rolling in seconds, spread in 30-60 seconds and migrated over the luminal surface of the platelet monolayer. Typical paths of migrating neutrophils are shown in Figure 1 . Although there was fluctuation in velocity with time and also variation between cells, a marked acceleration phase was evident when the velocity of a number of neutrophils was averaged at 1 minute intervals after stimulation with fMLP or PAF ( 
Role of adhesion molecules in migration over platelets
We used a panel of antibodies against platelet and neutrophil adhesion molecules to investigate mechanisms of migration induced by fMLP. When neutrophils were treated with anti-CD18 monoclonal antibody (R6.5E), included with superfused fMLP, rolling adhesion was maintained after activation and greater than 90% of the cells gradually detached from the platelet surface as previously described [4] . Thus, ␤2 integrins are essential for firm adhesion and migration of activated cells. Table 1 lists other antibodies used, their specificity and their effect on the mean rate of migration between 2 and 10 minutes of fMLP stimulation. Pretreatment of neutrophils with function-blocking antibodies against L-selectin, CD11a, ICAM-1, ICAM-3 or ␣v integrin (which inhibits binding to CD31 [14] ) did not alter migration velocity. Thus, these neutrophil-borne receptors have no evident role in regulating migration velocity across the luminal surface of platelet monolayers.
When neutrophils and platelets, or platelets alone were treated with antibody that blocked homophilic CD31 binding, we observed that the mean migration velocity was significantly reduced (Table 1) . Thus, although homophilic binding of platelet CD31 with neutrophil CD31 modulated migration velocity, interaction between CD31 and ␣v␤3 integrin did not. The perfusion of polyclonal antibody against P-selectin along with fMLP, or pretreatment of platelets with monoclonal anti-Pselectin antibody G1 significantly reduced the mean velocity of migration, but control antibodies had no effect ( Table 1) . Interaction of P-selectin with its neutrophil ligand thus appears to modulate the migration response, along with CD31. We therefore tested the outcome of a simultaneous blockade of platelet P-selectin and CD31 on migration rate, and found that the antibodies had additive effects (Table 1) .
More detailed analysis of the migratory velocity of neutrophils at 1 minute intervals after stimulation with fMLP is shown in Figure 3 , in the presence of antibodies against CD31, P-selectin or a combination of both. It is notable that migration started at a similar velocity and that acceleration occurred for each treatment, but that the antibodies decreased the rate of acceleration and hence the final velocity. The data for the average migration velocity from 2 to 10 minutes, as shown in Table 1 , therefore represent a conservative estimate of the final effect of antibodies on migration rate. Control antibodies and the anti-adhesive antibodies that did not influence migration rate (Table 1 ) all gave curves for velocity against time that were close to those for untreated cells, with a marked acceleration from a slow start (for example, see Fig. 3 for monoclonal antibody 10B8). Data are mean ± SEM for 60 cells from three experiments. ANOVA showed a significant effect of time on migration velocity for all conditions (p < 0.01), but no significant difference between the conditions.
Neutrophil migration on purified P-selectin and CD31
For immobilized purified P-selectin (at 5 g ml -1 ), the migration responses of neutrophils after activation with fMLP or PAF (Fig. 2c,d ) were indistinguishable from those on platelets (Fig. 2a,b ) and average migration velocities were 10.6 ± 0.8 or 10.8 ± 0.9 m min -1 , respectively (mean ± SEM of 60 cells from three comparative experiments; data are not significantly different from the values for migration over the platelet surface). However, when comparing migration of neutrophils on purified P-selectin, CD31 or albumin alone as a control, it was evident that migration rate was dependent on the receptor density (Fig. 4 ). Albumin-coated microslides supported a mean rate of neutrophil migration over 2 to 10 minutes of about 6.5 m min -1 . Addition of P-selectin or CD31 at increasing concentration caused a significant, dose-dependent increase in mean migration velocity with maximum of approximately 12 m min -1 at a concentration of 5 g ml -1 for either receptor (Fig. 4a,b) . Increasing the concentration of CD31 or P-selectin to 10 g ml -1 did not increase migration velocity further (data not shown). To mimic migration over platelets, 2.5 g ml -1 P-selectin and 2.5 g ml -1 CD31 were used in combination to coat the same microslide. A significant increase in migration velocity was evident when both receptors were present compared with either alone (Fig. 4c) . We used purified ICAM-1 to test whether modulation of migration velocity was a specific function of P-selectin and CD31. When ICAM-1 was immobilized on microslides using concentrations of 1 or 10 g ml -1 , migration velocities were 6.7 ± 0.7 and 6.9 ± 0.9 m min -1 , and were not significantly different from the velocity on albumin alone (6.9 ± 1.2; all data are mean ± SEM from three experiments). Figure 5 shows the migratory velocity of neutrophils at 1 minute intervals after stimulation with fMLP on ICAM-1, albumin or CD31/P-selectin mixture. Again, all surfaces allowed an acceleration of migration for up to approximately 6-7 minutes. Interestingly, albumin and ICAM-1 sustained migration rates equivalent to those observed on platelet monolayers after both CD31 and P-selectin had been blocked with antibodies ( Fig. 3 ).
We used antibodies labelled with radioactive iodine to test how the levels of purified proteins immobilized on microslides increased with the coating concentration used, and to see whether levels were physiologically relevant. Increasing amounts of antibody were bound as the Effect of antibody blockade on migration velocity measured at 1 min intervals for neutrophils migrating on immobilized platelets. Data are mean ± SEM for 60 cells from three experiments. Error bars for the individual antibody treatments are not shown for clarity, but error bars from other treatments are representative. ANOVA showed that there was a significant effect of time on migration velocity for all treatments (p < 0.01), and that velocity after treatment with individual blocking antibodies was significantly different from velocity without treatment (p < 0.01). ANOVA also showed that the effects of individual blocking antibodies did not differ, but that their combination produced different effects from the individual antibodies (p < 0.01). Non-blocking control Anti-P-selectin Table 1 Effects of antibodies on the migration velocity of neutrophils adherent to a platelet monolayer.
Leu-8 1 9.6 ± 0. concentrations of CD31, P-selectin or ICAM-1 were raised (Fig. 6) . Furthermore, the levels of CD31 (11.4 pg mm -2 bound antibody) and P-selectin (109.1 pg mm -2 bound antibody) on platelet monolayers were equivalent to those when approximately 2.5-3.5 g ml -1 of the purified proteins were used to coat microslides (Fig. 6a,b ).
Discussion
We have demonstrated for the first time that when neutrophils migrate over the surface of immobilized platelets or adhesion receptors, there is a distinct acceleration phase lasting for about 8 minutes after the delivery of an activating agent, and that the acceleration and final velocity of the neutrophils are dependent on the adhesive substrate. More specifically, we have shown that Pselectin and CD31 have complementary abilities to regulate the rate of migration supported by ␤2 integrin, as revealed by the effects of antibody blockade of the receptors on immobilized platelets, and by studies using the purified receptors coimmobilized with albumin. Purified ICAM-1 had no such regulatory ability.
Acceleration of migration was demonstrated by the use of a flow system that allowed us to follow the early responses of neutrophils to fMLP or PAF. We are not aware of a previous description of such early responses, although the final migration velocities that we obtained by this method are consistent with those previously measured, for instance in Zigmond chambers [20] . Maher et al. [11] demonstrated that the measured velocity of migration depended on the increments of time over which displacements were measured, because short-term rapid movements were not all in the same direction, and so produced a lower average value over a prolonged period. For 1 minute intervals (as used here), neutrophils adherent to albumin moved with a mean velocity of 7.4 m min -1 , but application of a gradient of fMLP across the cells increased velocity to 10-20 m min -1 , depending on the steepness of the gradient [11] . Migration velocity of neutrophils has also been shown to vary with temperature and pH [21] , but has not been shown previously to vary as Average migration velocity of neutrophils 2-10 min after activation with fMLP (10 -7 M) on different immobilized proteins at various concentrations. (a) Albumin alone (Alb) or in combination with P-selectin; (b) albumin alone or in combination with CD31; (c) albumin alone or in combination with P-selectin (P-sel) and/or CD31 at 2.5 g ml -1 . Data are mean ± SEM of three experiments. ANOVA showed a significant effect of concentration for P-selectin or CD31, and for individual compared to coimmobilized receptors (all p < 0.01); * p < 0.05, † p < 0.01 compared to albumin alone by paired t test. ‡ p < 0.01 for Pselectin and CD31 alone compared to the combination by paired t test. 
Figure 5
Migration velocity measured at 1 min intervals for neutrophils migrating on immobilized albumin (1%); albumin (1%) with purified Pselectin/CD31 mixture (2.5 g ml -1 of each); or albumin (1%) with ICAM-1 (10 g ml -1 ). Data are mean ± SEM for 60 cells from three experiments. Error bars for albumin are not shown, for clarity, but error bars from ICAM-1 are representative. ANOVA showed that there was a significant effect of time on velocity for all treatments (p < 0.01), and that velocity on P-selectin/CD31 differed from velocity on albumin alone or with ICAM-1 (p < 0.01), but that velocities on albumin and ICAM-1 did not differ. P-selectin presented either by immobilized, activated platelets or in purified form, supported rolling adhesion of neutrophils until they were activated, in agreement with previous studies [4, 23] . Here, anti-CD18 monoclonal antibody inhibited the conversion from rolling adhesion to stationary adhesion on platelets and abolished subsequent migration, consistent with earlier reports that CD11b/CD18 mediated these phenomena [4, 5] . Blocking CD11a had no effect on stopping or migration phases here, again as previously noted [4, 5] . We previously found that the initial stopping phase was due to activation of constitutively expressed CD11b/CD18, whereas prolonged adhesion was dependent upon a switch to newly expressed integrin [4] . Continual upregulation of CD11b/CD18 has also been shown to be necessary for prolonged attachment and neutrophil migration on albumin-coated surfaces [9] . It seems, therefore, that regulated adhesion via CD11b/CD18 underlies migration of neutrophils in our models. It is also notable that the kinetics of neutrophil acceleration described here resemble the time-course of de novo expression of CD11b/CD18 and the loss of adhesion of activated constitutively expressed CD11b/CD18 previously demonstrated [4] , suggesting that velocity may be dependent on turnover of this adhesion molecule. The other major factor likely to control rate of migration is the polymerization and redistribution of cytoplasmic and cytoskeletal-associated actin which is required for locomotion [7, 24] . Thus, the accessory signals generated by ligation of P-selectin and CD31 probably regulate the function of CD11b/CD18 and/or of cytoskeletal actin.
P-selectin and CD31 acted to regulate the rate of neutrophil migration in an additive but independent manner: the velocity of migration on platelets was reduced by antibodies against either receptor, and the inhibitory effects of the individual interventions were additive; the velocity of migration on purified P-selectin or CD31 also increased in a concentration-dependent manner, and an additive increase was found if the two were combined at suboptimal concentrations. An acceleratory phase was manifest for all surfaces, with or without antibodies. We thus advance the hypothesis that neutrophils can accelerate to a certain velocity (~6 m min -1 in this study) without auxiliary signals, but that signals transduced by the interactions of P-selectin and/or CD31 with their neutrophil counterligands amplify the acceleration so that a greater maximum velocity is achieved. Amplification might act, for example, by increasing the integrin turnover or actin assembly described above, or by altering the avidity of integrins for substrate [7] . Although increased or decreased adhesive avidity per se might explain changes in the rate of migration without the need to invoke signalling, this does not seem to explain the action of P-selectin or CD31 in these studies. When ICAM-1 was immobilized with albumin, increased binding of ␤2 integrins was evidenced by a 2.5-fold increase in the number of adherent neutrophils (mean of two experiments; others showed qualitatively similar effect), but migration velocity was unchanged. Nor can competitive loss of avidity induced by colocalization of CD31 and/or P-selectin explain the increase in velocity: binding of neutrophils to albumin was unaltered by colocalization of CD31 (data not shown); in addition, binding to P-selectin is known to be impaired over minutes following neutrophil activation [25] , so that if the mechanism was one of altered traction, neutrophils should have reverted to their velocity on albumin with time. Thus, we conclude that the binding of ligands to CD31 and P-selectin acts to modulate the migration supported by CD11b/CD18, rather than to support migration directly. In the case of P-selectin, transduction of a signal to neutrophils is presumably via the membrane glycoprotein PSGL-1, which bears sialylated sugars that are recognized specifically by this receptor [26] . PSGL-1 has been demonstrated to mediate the rolling of neutrophils on transfectants bearing P-selectin [27] , and we have found that anti-serum to PSGL-1 ablates adhesion of flowing neutrophils to platelets (unpublished observations). Signalling via interaction of P-selectin with its ligand is a novel observation for neutrophils, although both binding of P-selectin to monocytes in suspension [28] and the interaction of PSGL-1 on monocytes with platelet-borne P-selectin [29] enhance the response to subsequent activating stimuli. Upon neutrophil activation, membrane distribution of PSGL-1 is altered at the same time as the loss of adhesive function noted above [25] . In the current model, the P-selectin-PSGL-1 interaction appeared to influence migration velocity for at least 10 minutes after cell activation, so that loss of adhesive function of PSGL-1 might not be synonymous with loss of signalling function, or alternatively, a signal transduced at an early stage of migration might have had a lasting effect.
In the case of CD31, only homophilic interactions modulated neutrophil migration velocity. Blockade of an alternative ligand (␣v␤3 integrin) had no effect. CD31 has previously been demonstrated to regulate the activity of ␤1 or ␤2 integrins on a number of cells, including neutrophils [16] [17] [18] , by a process involving the mobilization of cAMP [19] . In addition, CD31-mediated contact between transfected cells in a wound-healing assay modulates their migration velocity [30] . The ability of CD31 to regulate migration rate is thus consistent with previous demonstrations of its signalling capacity, and with findings that antibody blockade inhibits migration of neutrophils through endothelium and its underlying matrix [12, 13] . The implication of our studies is that inhibition occurs via reduction in the migration rate or modulation of a linked function rather than by the blockade of adhesive capability per se.
Conclusions
Our findings indicate that the migration velocity of neutrophils is dependent on interactions with surface receptors that do not primarily support attachment itself, and enable us to propose a model that unifies signals from chemotactic agents and cell adhesion molecules (Fig. 7) . After activation, ␤2 integrins engage their counter-receptor, and the cytoskeletal motor of actin polymerization is upregulated along with the turnover of CD11b/CD18 (both in the sense of surface expression and of activation/deactivation) to drive and support neutrophil migration. Although a basal rate of migration is achieved on 'neutral' surfaces without 'auxiliary' receptors, additional ligation of P-selectin transduces information into the cell modulating a ratedetermining step, such as cytoskeletal actin polymerization or integrin turnover, in turn increasing the velocity of neutrophil movement. Signalling might act, for instance, through modulation of cytoplasmic Ca 2+ , which is known to be able concurrently to regulate cytoskeletal rearrangement, integrin function and neutrophil motility [31] . The presence of CD31 on the adhesive substrate operates to increase migration in a similar manner by engaging neutrophil CD31. When both P-selectin and CD31 are present on the adhesive substrate, they simultaneously transduce information into the cell, and further increase the migration velocity.
In general, neutrophil migration requires spatial and temporal coordination of responses to a range of cues from Model of the modulation of neutrophil migration rate. (a) Upon activation by fMLP, neutrophil CD11b/CD18 engages a counterligand and supports migration which accelerates up to a limiting rate dependent on the cytoskeletal motor of actin polymerization, and on turnover of CD11b/CD18 (cyclic activation and deactivation combined with de novo expression). Integrin activation itself may be modulated by interaction with the actin cytoskeleton. (b) An activated neutrophil binds P-selectin on the substrate via PSGL-1, which transduces information into the cell resulting in increased activity of the cytoskeletal motor and/or turnover of CD11b/CD18; migration velocity is increased. (c) An activated neutrophil binds both P-selectin and CD31 on the substrate via PSGL-1 and CD31, respectively, which transduce information into the cell resulting in additive increase in activity of the cytoskeletal motor and/or CD11b/CD18 turnover; migration velocity is further increased.
chemical signals (such as PAF and bacterial peptides, in suspension or presented on a surface), and from adhesion molecules that not only support neutrophil attachment but may also act to modify responses to signals [7, 26] . Here, we have identified a novel form of cross-talk between adhesion receptors that modulates the rate of migration of neutrophils over platelets or purified receptors. Whereas platelets might support all stages of neutrophil capture and migration on a damaged vessel wall [3, 5] , regulation of migration by this route should also apply for endothelial cells that are able to present the same receptors [1, 2] . Thus, adhesive cross-talk may be an important factor in modulating the migration of neutrophils into tissue in a wide range of conditions. Our results also support the general concept that the function of 'adhesion molecules' may not always be to provide mechanical support but might also be to regulate functions such as motility. This proposal might explain why efficient cell function may require engagement of a number of distinct cell surface receptors that are not obviously needed for anchorage.
Materials and Methods
Antibodies
All monoclonal antibodies were isotype IgG1 unless otherwise stated. Monoclonal antibodies R6.5E (against CD18) and DA36 (against CD11a) were gifts of Martyn Robinson (Celltech); 15.2 (against ICAM-1) was a gift from Nancy Hogg (ICRF); Leu-8 (against L-selectin) was from Becton Dickinson. Monoclonal antibodies against CD31 were the function-blocking L133.1, recognizing domain 2 (Becton Dickinson), and 7E4, recognizing domain 3 (designated A082, from the 6th International CD Antigen Workshop; isotype IgG2), and non-blocking controls, 10B8, recognizing domain 5 (gift of Ian Collins, R and D Systems), and 9G11, recognizing domain 1 [16] . The monoclonal antibody against ␣v-integrin was L230 (ATCC), which blocked interaction with CD31 [14] . Monoclonal antibodies against P-selectin were G1 (adhesion blocking) and S12 (non-blocking) and were gifts from Rodger McEver (University of Oklahoma). Rabbit polyclonal anti-Pselectin was a gift of Michael Berndt (Baker Medical Research Institute). Non-specific rabbit polyclonal X0903 was from Dako. Monoclonal antibodies against ICAM-3 were Cal 3.10 and Cal 3.3 [32] and 186-269 (designated A041 from the 6th International CD Antigen Workshop; isotype IgG2).
Neutrophil isolation
Blood for neutrophil preparation was collected from normal volunteers into citrate phosphate dextrose adenine-1 (CPDA-1; Baxter Health Care). Neutrophils were separated using two-step density gradients of Histopaque (Sigma) as described previously [3, 4] . Cells were washed, counted by Coulter counter (Coulter Electronics) and adjusted to 1 × 10 6 ml -1 in 0.1% bovine serum albumin (BSA, fraction IV; Sigma) in phosphate buffered saline containing 1 mM Ca 2+ and 0.5 mM Mg 2+ (PBS; Sigma)
Immobilization of platelet monolayers in microslides
Microslides (Cam Lab) are glass capillary tubes with a rectangular cross-section of 0.3 × 3 mm, a length of 5 cm and good optical qualities. In order to provide a substrate that readily binds platelets, microslides were coated with 3-aminopropyltriethoxysilane (APES; Sigma) as previously described [3] . Blood for platelet preparation was collected into sodium heparin (CP Pharmaceuticals). Plateletrich plasma (PRP) was derived by spinning the blood at 300 × g for 5 min and removing the platelet-rich supernatant. Platelets were counted, adjusted to 2 × 10 8 ml -1 with PBS, loaded into microslides and incubated at room temperature for 40 min to allow them to sediment, adhere and form a confluent monolayer [3] . Unbound platelets were removed by washing prior to assay. Experiments were always conducted using autologous platelets and neutrophils.
Immobilization of purified adhesion receptors in microslides and quantitation of surface density
Affinity-purified recombinant P-selectin, CD31 or ICAM-1 (all produced from stably transfected CHO cells; gift of Ian Collins, R and D Systems) were dissolved in PBS in the range 1-10 mg ml -1 . The proteins were immobilized by incubating the desired concentration in an APES-treated microslide for 60 min at 37°C. Free protein-binding sites were blocked with 1% BSA for 60 min at 37°C. In some experiments, mixtures of proteins were coincubated for 60 min at 37°C followed by blocking with 1% BSA. To quantify the concentration of purified protein that was immobilized, chosen antibodies were radio-iodinated and the specific activity of antibody bound to increasing concentrations of immobilized adhesion receptors was measured. The anti-CD31 monoclonal antibody 9G11, the anti-ICAM-1 monoclonal antibody 15.2 and rabbit anti-P-selectin polyclonal antibody (RP) were aliquoted in reaction tubes in volumes of 10 l at a final concentration of 1 mg ml -1 , 1 mg ml -1 and 0.42 mg ml -1 respectively. 50 l of 0.25 M phosphate buffer pH 7.5, 5 l of Na 125 I (100 mCi ml -1 ; Amersham) and 10 l of Chloramine-T (0.56 mg ml -1 ) were added and incubated at room temperature for 1 min. The reaction was quenched by the addition of 100 l of tyrosine solution (1 mg ml -1 in 50 mM phosphate buffer, pH 7.5). Antibodies were recovered and purified by passage down a Sephadex P.D. 10 column (Pharmacia). Activity of the iodinated antibodies (counts min -1 ) was measured on a scintillation counter and converted to counts min -1 g -1 of antibody assuming a 75% recovery of the antibody loaded onto columns. Microslides coated with purified proteins were incubated with iodinated antibodies at concentrations of 7.5 g ml -1 for 15.2, 5.0 g ml -1 for 9G11 and 3.2 g ml -1 for RP, for 45 min at room temperature. Unbound antibody was removed with thorough washing in 0.1% BSA/PBS. Activity per microslide was measured by scintillation counter and was converted to pg of antibody mm -2 of microslide surface after subtraction of counts from antibody-treated albumin-coated control microslides. Determination of antibody binding to CD31 and P-selectin on the surface of platelets was carried out in an identical manner using microslides containing confluent platelet monolayers.
Adhesion and migration under conditions of flow
The adhesion assay was based on that recently described [4] . Microslides containing confluent platelet monolayers or purified adhesion receptors were attached to a Harvard syringe pump by means of flexible silicon tubing, and cell-free buffer or a suspension of neutrophils was drawn through the microslides using a microelectronic switching valve (Lee Products). A constant wall shear stress (0.05 Pa unless otherwise stated) was maintained in the microslide by choice of the appropriate flow rate. This equates to 0.5 dyn cm -2 and is at the low end of the physiological range of wall shear stress in post-capillary venules [33] . This stress was chosen so that large numbers of adherent neutrophils could be established, and to conserve perfused reagents and cells. In limited experiments, we verified that migration proceeded essentially unaltered at 0.1 and 0.2 Pa. Microslides were mounted on the stage of a microscope fitted with a video camera, monitor and recorder. For experiments in which selectins were present on the microslide surface (that is, platelet monolayers or purified Pselectin), neutrophil suspension was flowed over the adhesive substrate for 5 min to establish a large number (~1500 mm -2 ) of continuously rolling cells. Nonadherent cells were washed from the microslide by perfusing cell-free buffer (0.1% BSA in PBS) for 2 min. A video record was made in at least five fields of view to allow the number of adherent cells to be counted off-line and their rolling behaviour to be analyzed [3] . Rolling neutrophils were then activated on the adhesive surface by the continuous perfusion of either fMLP (10 -7 M) or PAF (10 -7 M). Upon exposure to chemotactic stimuli, neutrophils stopped rolling , underwent shape change and spread on the platelet surface [4] . After the initial period of spreading, neutrophils began to migrate across the platelet surface. The migratory response was then analyzed. A single field of rolling neutrophils (containing approximately 150 cells) was chosen and the response to chemotactic stimulation recorded by time-lapse videomicroscopy (using a 9-fold time condensation) for a duration of 10 min. The rate of migration was assessed off line. The outlines of 10 cells were traced onto acetate sheets overlying the video monitor. This process was repeated as the video record was moved forward in 1 min intervals for a total of 10 min (Fig. 1) . The screen size was calibrated using a stage micrometer and the movements of individual cells converted to migratory velocity in m min -1 by measuring the distance advanced by the leading cellular margin (Fig.  1b) . When selectins were not present on the microslide (purified ICAM-1, CD31 or albumin alone), there was no rolling adhesion, so that it was necessary to activate neutrophils with fMLP (10 -7 M) immediately prior to perfusion. To allow the direct adhesion of flowing neutrophils via activated integrins, low wall shear stress (0.0125 Pa) was applied for 1.5 min of cell perfusion. The wall shear stress was then returned to 0.05 Pa and a continuous video record of migration made from exactly 2 min after initial activation. In this way, we were able to follow migration from 2 to 10 min after activation. Migratory velocities were analyzed as before. Table 1 lists the antibodies used, their specificity, and working concentration. Neutrophils were treated with antibody for 15 min at room temperature before perfusion. Microslides containing confluent monolayers of platelets were treated with the relevant antibody for 15 min at room temperature prior to neutrophil perfusion. Platelet Pselectin was blocked in two manners: polyclonal antibody was perfused with fMLP over rolling neutrophils because pre-treatment of platelets abolished adhesion; platelets were pre-treated with monoclonal antibody (which was only available in smaller quantity) and preactivated neutrophils perfused at low stress to allow attachment as described above for purified CD31. Blockade of ICAM-3 function was achieved by treating neutrophils with a combination of A041 and Cal 3.10 as previously described [32] . The molecular basis for such a blocking regime is not clearly understood but the individual antibodies are not functionally effective.
Antibody interventions
Statistics
Concurrent effects of time and different treatment group were tested using two-way analysis of variance (ANOVA), followed by one-way ANOVA for effect of time on a single treatment where appropriate. Comparison of individual treatments or conditions at single time points were made by paired t test or unpaired (Student's) t test as appropriate.
